183 related articles for article (PubMed ID: 17177939)
1. Matrix metalloproteinases in the progression and regression of Kaposi's sarcoma.
Pantanowitz L; Dezube BJ; Hernandez-Barrantes S; Tahan SR; Dabbous MK
J Cutan Pathol; 2006 Dec; 33(12):793-8. PubMed ID: 17177939
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases 2 and 9, and extracellular matrix in Kaposi's sarcoma.
Bongiorno MR; Doukaki S; Ferro G; Aricò M
Dermatol Ther; 2010; 23 Suppl 2():S33-6. PubMed ID: 20482566
[TBL] [Abstract][Full Text] [Related]
3. Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study.
Dezube BJ; Krown SE; Lee JY; Bauer KS; Aboulafia DM
J Clin Oncol; 2006 Mar; 24(9):1389-94. PubMed ID: 16549833
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients.
Uccini S; Sirianni MC; Vincenzi L; Topino S; Stoppacciaro A; Lesnoni La Parola I; Capuano M; Masini C; Cerimele D; Cella M; Lanzavecchia A; Allavena P; Mantovani A; Baroni CD; Ruco LP
Am J Pathol; 1997 Mar; 150(3):929-38. PubMed ID: 9060831
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-4 receptor expression in vivo on human AIDS-related Kaposi's sarcoma.
Varricchio F; Husain SR; Leland P; Gill P; Puri RK
Oncol Res; 1997; 9(9):495-503. PubMed ID: 9495455
[TBL] [Abstract][Full Text] [Related]
6. Emerging targets and novel strategies in the treatment of AIDS-related Kaposi's sarcoma: bidirectional translational science.
Dezube BJ; Sullivan R; Koon HB
J Cell Physiol; 2006 Dec; 209(3):659-62. PubMed ID: 17001705
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus.
Järvinen TM; Kanninen P; Jeskanen L; Koskenmies S; Panelius J; Hasan T; Ranki A; Saarialho-Kere U
Br J Dermatol; 2007 Nov; 157(5):970-80. PubMed ID: 17854363
[TBL] [Abstract][Full Text] [Related]
8. Classic and immunodeficiency-associated Kaposi's sarcoma. Clinical, histologic, and immunologic correlations.
Santucci M; Pimpinelli N; Moretti S; Giannotti B
Arch Pathol Lab Med; 1988 Dec; 112(12):1214-20. PubMed ID: 3056319
[TBL] [Abstract][Full Text] [Related]
9. Intravascular Kaposi's sarcoma - a hitherto unrecognized phenomenon.
Luzar B; Antony F; Ramdial PK; Calonje E
J Cutan Pathol; 2007 Nov; 34(11):861-4. PubMed ID: 17944727
[TBL] [Abstract][Full Text] [Related]
10. Regression of AIDS-related Kaposi's sarcoma following combined antiretroviral treatment.
Monticelli A; Lewi D; Salomon H; Pampuro S; Libonatti O; Jauregui Rueda H; Hodara V
Rev Argent Microbiol; 2000; 32(4):206-8. PubMed ID: 11149154
[TBL] [Abstract][Full Text] [Related]
11. Collagenase-1 (MMP-1), matrilysin-1 (MMP-7), and stromelysin-2 (MMP-10) are expressed by migrating enterocytes during intestinal wound healing.
Salmela MT; Pender SL; Karjalainen-Lindsberg ML; Puolakkainen P; Macdonald TT; Saarialho-Kere U
Scand J Gastroenterol; 2004 Nov; 39(11):1095-104. PubMed ID: 15545168
[TBL] [Abstract][Full Text] [Related]
12. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of Kaposi's sarcoma in patients with acquired immunodeficiency syndrome in São Paulo, Brazil.
Yoshioka MC; Alchorne MM; Porro AM; Tomimori-Yamashita J
Int J Dermatol; 2004 Sep; 43(9):643-7. PubMed ID: 15357742
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of Bcl-2 in Kaposi's sarcoma lesions varies according to histopathologic stage, whereas expression of Bcl-x and Mcl-1 differs according to human immunodeficiency virus serologic status of patients.
Fernández-Figueras MT; Puig L; Fernández-Vasalo A; Esquius M; Montero MA; Ariza A
Mod Pathol; 2000 Apr; 13(4):438-45. PubMed ID: 10786812
[TBL] [Abstract][Full Text] [Related]
15. Oxytocin is a growth factor for Kaposi's sarcoma cells: evidence of endocrine-immunological cross-talk.
Cassoni P; Sapino A; Deaglio S; Bussolati B; Volante M; Munaron L; Albini A; Torrisi A; Bussolati G
Cancer Res; 2002 Apr; 62(8):2406-13. PubMed ID: 11956104
[TBL] [Abstract][Full Text] [Related]
16. Histological characterization of regression in acquired immunodeficiency syndrome-related Kaposi's sarcoma.
Pantanowitz L; Dezube BJ; Pinkus GS; Tahan SR
J Cutan Pathol; 2004 Jan; 31(1):26-34. PubMed ID: 14675282
[TBL] [Abstract][Full Text] [Related]
17. AIDS-associated Kaposi's sarcoma in Northeastern Nigeria.
Kagu MB; Nggada HA; Garandawa HI; Askira BH; Durosinmi MA
Singapore Med J; 2006 Dec; 47(12):1069-74. PubMed ID: 17139404
[TBL] [Abstract][Full Text] [Related]
18. The role of human immunodeficiency virus-I in the pathogenesis of acquired immunodeficiency syndrome-related Kaposi's sarcoma: the importance of an inflammatory and angiogenic milieu.
Dezube BJ
Semin Oncol; 2000 Aug; 27(4):420-3. PubMed ID: 10950368
[TBL] [Abstract][Full Text] [Related]
19. Prominent expression of metalloproteinases in early stages of ovarian tumorigenesis.
Cai KQ; Yang WL; Capo-Chichi CD; Vanderveer L; Wu H; Godwin AK; Xu XX
Mol Carcinog; 2007 Feb; 46(2):130-43. PubMed ID: 17131304
[TBL] [Abstract][Full Text] [Related]
20. Human herpesvirus 8 presence and viral load are associated with the progression of AIDS-associated Kaposi's sarcoma.
Laney AS; Cannon MJ; Jaffe HW; Offermann MK; Ou CY; Radford KW; Patel MM; Spira TJ; Gunthel CJ; Pellett PE; Dollard SC
AIDS; 2007 Jul; 21(12):1541-5. PubMed ID: 17630548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
